Multiagent imaging: from the pathophysiologic basis to clinical characterization and radionuclide therapy

Abstract

The remarkable growth of nuclear medicine in the past 20 years is attributable to a number of factors, including the clinical recognition that imaging with [F]FDG, touted as the ‘‘molecule of the millennium’’ [1], improves diagnosis and staging, especially when it is used with devices that provide anatomic reference for the metabolic images. Furthermore… (More)

Topics

Cite this paper

@inproceedings{Mariani2013MultiagentIF, title={Multiagent imaging: from the pathophysiologic basis to clinical characterization and radionuclide therapy}, author={Giuliano Mariani and H. William Strauss}, year={2013} }